Based on some google research, it' not clear to me that Paxlovid provides significant benefits for those who are vaxxed and "standard risk."
>>>And questions have grown about whether Paxlovid helps those who aren’t at high risk of serious disease—Pfizer earlier this month
halted a large trial of the drug in standard risk COVID-19 patients because it was failing to show statistically significant protection against death or hospitalization.<<<
https://www.science.org/content/article/bad-news-paxlovid-coronavirus-can-find-multiple-ways-evade-covid-19-drug
Here's a snip from the Phizer press release:
>>>In the EPIC-SR study of PAXLOVID™(nirmatrelvir [PF-07321332] tablets and ritonavir tablets), the novel primary endpoint of self-reported,
sustained alleviation of all symptoms for four consecutive days was not met, as previously reported<<<
Off hand, this surprises me somewhat. If Paxlovid stops reproduction of the virus, I would have expected it to reduce symptoms as well.
I'm going to keep taking Paxlovid as "insurance" against severe COVID, but it sounds like I can't expect it to significantly reduce symptoms.